Allergic Contact Dermatitis Mimicking Anti–Interleukin 17 Eczematous Eruption

Abstract

Get full access to this article

View all access options for this article.

References

Caldarola

, Pirro

, di Stefani

, et al. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. Expert Opin Biol Ther, 2020; 20(6):665–672 Available at: https://pubmed.ncbi.nlm.nih.gov/32045273/. Accessed April 12, 2022.

Todberg

, Zachariae

, Krustrup

, et al. The effect of treatment with anti–interleukin-17 in patients with allergic contact dermatitis. Contact Dermatitis, 2018; 78(6):431–432 Available at: https://pubmed.ncbi.nlm.nih.gov/29722024/. Accessed April 12, 2022.

Mufti

, Lu

, Sachdeva

, et al. Patch testing during immunosuppressive therapy: a systematic review. Dermatitis, 2021; 32(6):365–374 Available at: https://pubmed.ncbi.nlm.nih.gov/33896928/. Accessed April 12, 2022.

Magdaleno-Tapial

, Valenzuela-Oñate

, Ortiz-Salvador

, et al. Contact allergy to isothiazolinones epidemic: current situation. Contact Dermatitis, 2020; 82(2):83–86 Available at: https://pubmed.ncbi.nlm.nih.gov/31515812/. Accessed April 12, 2022.

Silverberg

, Hou

, DeKoven

, et al. Prevalence and trend of allergen sensitization in patients referred for patch testing with a final diagnosis of psoriasis: North American Contact Dermatitis Group data, 2001–2016. Contact Dermatitis, 2021; 85(4):435–445 Available at: https://pubmed.ncbi.nlm.nih.gov/33931870/. Accessed April 12, 2022.